Terumo Introduces New Radial to Peripheral (R2P™) Devices ... | 合法醫療器材資訊網

2019年9月26日—TerumoMedicalCorporation(TMC)todayannouncedthatithasintroducedtheR2PTMMISAGO®RXSelf-expandingPeripheralStentatthe ...

​

Terumo Medical Corporation (TMC) today announced that it has introduced the R2PTM MISAGO® RX Self-expanding Peripheral Stent at the 31st Transcatheter Cardiovascular Therapeutics (TCT) Conference, the world’s premier educational meeting specializing in interventional cardiovascular medicine. The introduction of R2PTM MISAGO® helps physicians bring the benefits associated with a radial access approach to patients with peripheral artery disease (PAD).

According to the US Centers for Disease Control and Prevention (CDC), PAD affects approximately 8.5 million people in the United States (US) and is characterized by a narrowing or blockage of arteries limiting blood flow to the lower extremities; an endovascular approach is often used for treatment.1,2

R2PTM MISAGO® is a device within the Radial to Peripheral (R2PTM) Portfolio, the first and only portfolio of longer-le...